APP and Alzheimer disease: In particular, a key study demonstrated that the mRNA and protein levels for ColVI are elevated in the hippocampal neurons of Alzheimer's disease patients, as well as in a commonly used transgenic mouse model of Alzheimer's disease expressing mutant human amyloid precursor protein (APP; Box 1) (Cheng et al., 2009).